TGF beta 1 Human ProcartaPlex™ Simplex Kit
TGF beta 1 Human ProcartaPlex™ Simplex Kit
Invitrogen™

TGF beta 1 Human ProcartaPlex™ Simplex Kit

ヒトTGFβ1シンプレックスProcartaPlexキットは、TGFβ1タンパク質を測定し、Luminex xMAP技術を利用してタンパク質を検出/定量します。ProcartaPlexヒト基本キット(カタログ番号EPX010-10420-901)は、TGF-B1ヒトProcartaPlexシンプレックスキットの使用に必要です。TGF-B1測定には、サンプルの活性化が必要です詳細を見る
製品番号(カタログ番号)数量
EPX01A-10249-90196テスト
製品番号(カタログ番号) EPX01A-10249-901
価格(JPY)
59,000
Each
お問い合わせください ›
数量:
96テスト
ヒトTGFβ1シンプレックスProcartaPlexキットは、TGFβ1タンパク質を測定し、Luminex xMAP技術を利用してタンパク質を検出/定量します。ProcartaPlexヒト基本キット(カタログ番号EPX010-10420-901)は、TGF-B1ヒトProcartaPlexシンプレックスキットの使用に必要です。TGF-B1測定には、サンプルの活性化が必要です(手順を参照)。TGF-B1ヒトProcartaPlexシンプレックスキットを他のProcartaPlexシンプレックスキットと組み合わせることは推奨されません。

Luminexプラットフォーム用ProcartaPlexアッセイ

ProcartaPlexイムノアッセイは、サンドウィッチELISAの原理に基づき、1つのタンパク質の異なるエピトープに結合した2種類の特異性の高い抗体を使用し、Luminex機器を使用してすべてのタンパク質ターゲットを同時に定量します。ProcartaPlex マルチプレックスアッセイは、わずか 25 µL の血漿または血清、あるいは 50 µL の細胞培養上清のみを必要とし、分析結果を得るために要する時間もわずか 4 時間です。

サンプルあたりの結果の増加—25~50 µLのサンプル1つで複数のタンパク質ターゲットを同時に測定

定評のあるLuminex技術—高参照マルチプレックスプラットフォームによるタンパク質の検出および定量

ProcartaPlexアッセイでは、Luminex xMAP(多項目同時測定プロファイリング)技術を利用して、25~50 µLのサンプル1つで最大65のタンパク質ターゲット(血漿、血清、細胞培養上清、およびその他の体液)を同時に検出および定量できます。

ProcartaPlexアッセイのLuminexビーズは、赤色および赤外フルオロフォアの正確な比率で内部染色されており、Luminex xMAP検出システム(例:Luminex 200、FLEXMAP 3D、MAGPIX)で同定できます。ProcartaPlexアッセイは、サンドウィッチELISAと同様に、マッチングした抗体ペアを使用して目的のタンパク質を同定します。マルチプレックスアッセイでは、各スペクトルに固有のビーズは単一の標的タンパク質に特異的な抗体で標識され、結合したタンパク質はビオチン化抗体およびストレプトアビジン-R-フィコエリトリン( RPE)で同定されます。タンパク質特異的抗体の特異的なビーズへの結合により、1 つのウェルで複数のターゲットの分析が可能になります。

ProcartaPlex アッセイと ELISA の最も大きな違いは、ProcartaPlex アッセイの捕捉抗体がビーズに結合され、マイクロプレートウェルに吸着されないことです。そのため、ProcartaPlex アッセイ試薬は溶液中で自由に浮遊します。たとえば、Luminex 200装置は検出用に2つのレーザーを備えています。1つは各ビーズのスペクトル特性を識別するためのレーザーで、もう1つはサンプル中のタンパク質量に比例したRPE蛍光量を定量するためのレーザーです。ProcartaPlexマルチプレックスアッセイは、従来のサンドウィッチELISAの実行に要する時間で、大幅に少ないサンプル量を使用して、より多くのターゲットタンパク質をプロファイルできます。

ProcartaPlexマルチプレックスパネルは、6種の生物種(ヒト、マウス、ラット、ヒト以外の霊長類、ブタ、イヌ)にわたって複数のフォーマットで利用可能です。各タンパク質ターゲットの包括的なリストなど、詳細については、thermofisher.com/procartaplexをご覧ください。
研究用途にのみご使用ください。診断目的には使用できません。
仕様
アッセイ範囲ロット1で決定されたとおり:1.1-4500 pg/mL
アッセイ感度15%未満
ビーズタイプTGFβ1 [29]
使用対象 (装置)Luminex™ 装置
フォーマットシンプレックスキット
遺伝子増殖因子β1の変換
遺伝子別名CED、DPD1、LAP、TGFB、TGFβ
遺伝子ID(Entrez)7040
遺伝子記号TGFB1
製品ラインProcartaPlex
タンパク質増殖因子β1の変換
タンパク質サブタイプTGF-β-1、LAP
サンプルタイプ血清、血漿、細胞培養上清
サンプル量血清、血漿:25 μL、CCS:50 μL
出荷条件湿氷
UniProt IDP01137
CombinabilityCombinable
製品タイプシンプレックスキット
数量96テスト
Research AreaImmunology
Human
Unit SizeEach
組成および保存条件
  • キャプチャービーズ(50X)バイアル1本
  • ビオチン化検出抗体(50X)バイアル1本
  • ヒト標準TGFβ1(凍結乾燥)バイアル2本
  • 2~8℃で保存してください。

よくあるご質問(FAQ)

What is the size of the Luminex beads you currently use?

The beads used in our Luminex instrument-compatible ProcartaPlex and QuantiGene Plex assays are 6.5 micron superparamagnetic beads.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

I am interested in performing Luminex assays using BioSource kits, and I have a Luminex xMAP system. Besides the kits and system, what other reagents and equipment will I need?

The following is a list of general lab supplies that are required for running BioSource immunoassays on the Luminex xMAP system:
1) Sonicating water bath
2) Orbital shaker
3) Vortexer
4) Repeating and/or multi-channel pipetter (not required, but recommended)
5) Calibrated adjustable precision pipettes, with disposable plastic tips
6) Glass/plastic tubes and racks for preparing reagents
7) Graduated cylinder and container for preparing wash solution
8) Aluminum foil
9) Deionized or distilled water.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Do the Luminex beads require special care in handling?

The Luminex beads should be protected from light because they are susceptible to photobleaching. We recommend protecting the beads by keeping containers covered with aluminum foil during all incubation steps, and exercising care during handling. The beads should not be frozen, subjected to excessive heat, or exposed to organic solvents.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Why would the Luminex acquisition software display "Sample Empty" messages during analysis?

(1) The user did not properly aliquot the diluted beads, such that no beads were actually added to the wells (make sure that the bead concentrates are sonicated and vortexed well, then check the pipet tip to ensure that air bubbles were not drawn up)
(2) The user missed loading diluted beads to some wells, which is likely since the small volume is clear and difficult to visualize in the clear plastic plate (we have now addressed this customer difficulty by coloring each of the Buffer Reagent Kit components)
(3) The user applied too much vacuum pressure at some point during the wash steps, or allowed the pressure to spike even once, such that the filter membrane tore in a few wells releasing the beads (make sure that the vacuum manifold pressure is kept below 5mm/in Hg, depending on their system -- a good rule of thumb is that it should take a full 3-second count to GENTLY empty the wells of 200uL)
(4) The user did not properly sonicate and vortex the beads prior to dilution, such that the percent of bead aggregation was high and the instrument was unable to find enough single beads to meet the events/bead value designated by the customer (make sure that the Bead Concentrate tube is put into the waterbath all the way to the cap, since the tube is hollow until the top third)
(5) The user lost beads by shaking the plate too aggressively or handling it improperly (make sure that the orbital shaker is set to a speed that allows for maximum vortex in the wells without spillage)
(6) The user exposed the beads to an excess of light during storage or running of the assay, such that some but not all of the beads were photobleached and therefore falling outside the acceptable range for each bead region (make sure that the plate is covered on the top/sides with foil throughout the assay, away from Windows and spotlights, and that the bead component of the kits is stored in the dark)*
(7) There was a clog in the sample needle, such that the instrument was unable to take up enough sample to meet the number of events requested per bead region (suggest that the user follow the manual instructions for dislodging a clog, which include several Back Flush steps and may require removal of the needle for sonication with probe alignment).

* Some of the older Antibody Bead Kits still have clear plastic tops instead of black ones. In cases where customers store kits in lit refrigerators, or keep them open on the lab bench, even a few hours of light exposure is enough to photobleach beads. It is important to note, in general, that higher number bead regions are more susceptible to photobleaching. In order to draw conclusions about the source of the difficulty, we would ask to see the data, specifically the Masterplex QT file, which would enable us to examine the pattern of "Sample Empty" occurrences in addition to the bead counts per well.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

What are the Luminex beads made of?

The beads are made of polystyrene.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

引用および参考文献 (4)

引用および参考文献
Abstract
Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T-cell activation, and serum levels of TGF-beta.
Authors:Chalupa P, Davidová A, Beran O, Arientová S, Boštík P, Kapla J, Kondelková K, Plíšek S, Holub M
Journal:APMIS
PubMed ID:27307383
'The aim was to analyze T-regulatory cells (Tregs), activated CD8(+) T cells, and transforming growth factor-beta (TGF)-ß in hepatitis C patients. We enrolled 31 patients with chronic genotype 1 hepatitis C virus (HCV) infection, 30 seropositive persons with spontaneous HCV elimination, and 23 healthy volunteers. The patients were examined at ... More
Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFa) as a potential biomarker of consumption and dual diagnosis.
Authors:Maza-Quiroga R, García-Marchena N, Romero-Sanchiz P, Barrios V, Pedraz M, Serrano A, Nogueira-Arjona R, Ruiz JJ, Soria M, Campos R, Chowen JA, Argente J, Torrens M, López-Gallardo M, Marco EM, Rodríguez de Fonseca F, Pavón FJ, Araos P
Journal:PeerJ
PubMed ID:29038767
Cocaine use disorder (CUD) is a complex health condition, especially when it is accompanied by comorbid psychiatric disorders (dual diagnosis). Dual diagnosis is associated with difficulties in the stratification and treatment of patients. One of the major challenges in clinical practice of addiction psychiatry is the lack of objective biological ... More
Human Adipose-Derived Mesenchymal Stem Cells Respond to Short-Term Hypoxia by Secreting Factors Beneficial for Human Islets In Vitro and Potentiate Antidiabetic Effect In Vivo.
Authors:Schive SW, Mirlashari MR, Hasvold G, Wang M, Josefsen D, Gullestad HP, Korsgren O, Foss A, Kvalheim G, Scholz H
Journal:Cell Med
PubMed ID:28713640
Adipose-derived mesenchymal stem cells (ASCs) release factors beneficial for islets in vitro and protect against hyperglycemia in rodent models of diabetes. Oxygen tension has been shown to induce metabolic changes and alter ASCs' release of soluble factors. The effects of hypoxia on the antidiabetic properties of ASCs have not been ... More
Haplotypes of FOXP3 genetic variants are associated with susceptibility, autoantibodies, and TGF-ß1 in patients with systemic lupus erythematosus.
Authors:Stadtlober NP, Flauzino T, da Rosa Franchi Santos LF, Iriyoda TMV, Costa NT, Lozovoy MAB, Dichi I, Reiche EMV, Simão ANC
Journal:Sci Rep
PubMed ID:33686190
The aim of this study was to evaluate the association of rs2232365 (-924 G?>?A) and rs3761548 (-3279 C?>?A) FOXP3 variants with systemic lupus erythematosus (SLE) susceptibility, TGF-ß1 plasma levels, autoantibodies, and LN nephritis, and SLE disease activity index (SLEDAI). The study included 196 SLE female patients and 157 female controls. ... More